Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,248,870
-$135,213 QoQ
Shares Held
9,885
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#984
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. GILD ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,248,870 | 9,885 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,384,083 | 9,931 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,318,718 | 10,744 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,274,724 | 11,484 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,315,361 | 11,864 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,359,614 | 12,134 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,250,320 | 13,536 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,269,337 | 15,140 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,050,076 | 15,305 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,099,116 | 15,005 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,484,508 | 18,325 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,469,573 | 19,610 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,624,712 | 21,081 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,753,239 | 21,131 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,856,849 | 21,629 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,826,702 | 29,611 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,167,058 | 35,060 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,106,610 | 35,435 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,616,864 | 36,040 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,567,686 | 36,760 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,554,843 | 37,102 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,427,955 | 37,567 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,221,104 | 38,124 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,322,485 | 36,754 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $2,824,775 | 36,714 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,854,635 | 38,184 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||